ORIGINAL REGIMEN OF SUBCUTANEOUS INTERLEUKIN-2 (IL2) AND INTERFERON-ALPHA (IFN) IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA (MRCC) INELIGIBLE TO RECEIVE INTRAVENOUS (IV) IL2
B. Escudier et al., ORIGINAL REGIMEN OF SUBCUTANEOUS INTERLEUKIN-2 (IL2) AND INTERFERON-ALPHA (IFN) IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA (MRCC) INELIGIBLE TO RECEIVE INTRAVENOUS (IV) IL2, European journal of cancer, 31A, 1995, pp. 470-470